Skip to content

Effect of transcranial magnetic stimulation under neuronavigation on patients with Alzheimer's disease

Effect of transcranial magnetic stimulation under neuronavigation on patients with Alzheimer's disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050119
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-08-17
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease (AD)

Interventions

20HZ group:20HZ Transcranial Magnetic Stimulation
iTBS group:TBS Transcranial Magnetic Stimulation

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 55-80 years; 2. Clinically diagnosed as possible AD according to NINCDS-ADRDA criteria; 3. MMSE score >=10 points and <=24 points; 4. CDR score is 0.5-2 points; 5. Before the baseline period, use a stable dose of cholinesterase inhibitor or memantine; 6. The patient himself and his family were informed and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with clinical features or pathological changes (such as visual hallucinations, Parkinson's syndrome, motor neuron disease, asymmetric dystonia and myoclonus, ataxia, etc.) suggesting dementia types other than AD (such as dementia with Lewy bodies, frontotemporal dementia, corticobasal degeneration, Creutzfeldt-Jakob disease, etc.); 2. Those who have a history of major head trauma or mental and nervous system diseases (such as severe depression); 3. Patients with major physical diseases such as heart, liver, and kidney cannot tolerate this study; 4. Received MECT treatment within three months; 5. Those who have a history of epilepsy or a first-degree relative with a history of epilepsy or other neurological diseases; 6. Contraindications for MRI examination and TMS treatment: with cardiac pacemaker, neurostimulator, artificial metal heart valve, intracranial aneurysm clip, intraocular metal foreign body, cochlear implants and other metal implants (except oral braces); pregnancy, claustrophobia, history of epilepsy.

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Rating Scale - Cognitive Score;

Secondary

MeasureTime frame
Simple Mental State Examination Scale Score;Neuropsychiatric Scale Score;Activities of Daily Living Scale Score;Clinical Dementia Rating Scale Score;Hamilton Anxiety Scale Score;Hamilton Depression Scale Score;

Countries

China

Contacts

Public ContactNing Yuping

The Affiliated Brain Hospital of Guangzhou Medical University

ningjeny@126.com+86 20 81268720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026